10X Genomics

Traded on the St. Petersburg Stock Exchange
10x Genomics is an American biotechnology company that develops software for analyzing biological systems such as genetic and immune cells. 10x Genomics was founded in 2012 by Serge Saxonov, Ben Hindson and Kevin Ness to create advanced testing equipment for use in cellular biology. It is headquartered in Pleasanton, California.
10X Genomics stock price chart
-80%
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

10X Genomics balance sheet

Report period2017 2018 2019 2020 2021
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

10X Genomics cash flows

Report period2017 2018 2019 2020 2021
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

10X Genomics multipliers

Report period2017 2018 2019 2020 2021
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

10X Genomics profitability

Report period2017 2018 2019 2020 2021
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
10X Genomics assets
10X Genomics cash flows

10X Genomics dividend policy

The company doesn't provide dividend

10X Genomics shares

TickerNameTypeNominal valueISINPrice
TXG:US10X GenomicsCommon share-US88025U1097$28.48
10X Genomics news
05.05.2022
10X Genomics reported a GAAP loss of $42.413 million for the 3 months of 2022, up 3.7 times from $11.551 million in the prior year. Revenue increased 8.2% to $114.496 million from $105.821 million a year earlier.
17.02.2022
10X Genomics' GAAP loss for 2021 was $58.223 million, down 9.4 times from $542.731 million in the previous year. Revenue increased 64.1% to $490.49 million from $298.845 million a year earlier.
05.11.2021
10X Genomics' GAAP loss for 9M 2021 was $39.774 million, down 3.2 times from $127.158 million in the prior year. Revenue increased 85.9% to $346.96 million from $186.627 million a year earlier.
25.10.2021
10x Genomics opened its first manufacturing facility outside the U.S. in Singapore. The center is designed to produce a core portfolio of consumables for single-cell and spatial analysis. The facility also serves as a commercial hub in the APAC, strengthening sales, marketing and customer support in the region.
General information
Company name10X Genomics
SectorHealth Care / Health Care Equipment & Services / Health Care Technology / Health Care Technology
Business address6230 Stoneridge Mall Road Pleasanton, CA 94566 United States
Mailing address6230 Stoneridge Mall Road Pleasanton, CA 94566 United States
Websiteinvestors.10xgenomics.com
Information disclosurewww.sec.gov